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Abstract
Medication adherence in persons treated for human immunodeficiency virus (HIV) continues to be
an important focus for intervention. While high levels of adherence are required for good clinical
outcomes, research shows many patients do not achieve these levels. Despite multiple
interventions to improve adherence, most require multiple sessions delivered by trained clinicians.
Cost and lack of trained personnel limit the availability of these interventions. Alternatives to
clinician-delivered interventions are interventions provided via electronic devices (eg, personal/
tablet computers and smartphones). Modern technology allows devices to provide tailoring of
content to patient characteristics and learning needs, and to be excellent platforms to deliver
multimedia teaching content. The intervention reported drew on research on health literacy in
persons with HIV and the relation of health literacy to medication adherence in persons treated for
HIV to develop an electronically delivered application. Using the Information–Motivation–
Behavioral Skills model as a conceptual framework for understanding patients’ information needs,
a computer-delivered intervention was developed, its usability and acceptability was assessed, and
medication adherence in 118 patients for 1 month before and after they completed the intervention
was evaluated. Changes in participant adherence were evaluated in sequential models with
progressively lower levels of baseline medication adherence. Results show that although changes
in adherence in the entire sample only approached statistical significance, individuals with
adherence less than 95% showed significant increases in adherence over time. Participants’ self-
reported knowledge and behavioral skills increased over the course of the study. Their change in
information predicted their post-intervention adherence, suggesting a link between the
intervention’s effects and outcomes. A computer-delivered intervention targeting HIV-related
health literacy may thus be a useful strategy for improving patient adherence.
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Introduction
Human immunodeficiency virus (HIV) infection can be effectively treated with combination
antiretroviral therapy, but successful treatment requires that patients maintain high levels of
adherence to their medications. Required levels of adherence are at least 80%–90% (and
perhaps much higher),1–3 but the typical average level of adherence in many studies has
been much lower in the range of 50%–60%.4,5 High levels of adherence are important for
several reasons. First, medication adherence is associated with clinical outcomes.6,7 In
addition, several studies have shown that individuals with low levels of virus, often obtained
with good adherence, are less likely to transmit HIV to other persons.8 Medication
adherence is therefore important not only for patients’ health but also for public health, and
new interventions to improve patient adherence are important.
Theories of health behavior have been used to develop interventions to promote adherence,
and many have been successful. Theories such as the Information–Motivation–Behavioral
Skills (IMB) model,9 the Health Belief Model,10 and the Theory of Planned Behavior,11 as
well as empirical research on factors associated with poor adherence, have been the basis for
various effective interventions.12,13 These interventions have usually targeted individuals’
beliefs or knowledge about the disease or its treatment based on the core idea that if patients
understand the importance of adherence and the consequences of nonadherence they will be
more likely to take their medications regularly. Other interventions also focus on barriers to
adherence, such as substance abuse or depression, or on specific adherence-related
skills.13,14
Effective evidence-based interventions exist but are not always available to those who need
them. Successful interventions often involve multiple elements such as patient education,
reminders, and changes in dosing schedule or format, and require significant clinician
(physician, nurse, pharmacist, and other health care provider) time.15 Although clearly an
important role for those focused on saving patients’ lives by improving their adherence to
critically important medications, some tasks are likely repetitive and don’t require highly
skilled clinicians. One strategy that might reduce the burden of providing adherence
interventions is to create ways in which they can be delivered using electronic technologies.
Although initially more expensive to develop, electronic interventions can be delivered to
patients at low cost and with little clinician input on existing computers or over the Internet
on mobile devices. While they are not as flexible as those delivered by trained clinicians,
electronic interventions may be able to deliver similar intervention content. By doing so,
busy clinicians may be released from routine educational duties to cope with more complex
problems that demand their attention. These interventions would not replace clinicians but
reduce the demands on their time made by routine tasks and allow them to provide critically
important support to patients.
An important factor in patients’ medication adherence that could be addressed in an
electronic intervention is patient level of health literacy. Health literacy has been shown in
multiple studies to be an important factor in individuals treated for HIV. Kalichman and
Rompa, for example, found that low levels of health literacy correlated with lower CD4 cell
counts, higher viral loads, and number of hospitalizations.16 In another study, Kalichman et
al showed that patients with lower health literacy had less knowledge about HIV and its
treatment.17 Finally, poor health literacy also is related to lower levels of medication
adherence in patients with HIV.18 These findings show that health literacy might be a likely
target for an intervention to improve patient medication adherence.
Health literacy has been defined as “the degree to which individuals have the capacity to
obtain, process, and understand basic health information and services needed to make
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appropriate health decisions.”19 This definition is broad and doesn’t readily lead to a
strategy for improving patients’ health literacy. A theory of health behavior that has already
been used to develop interventions to improve medication adherence in persons with HIV is
the IMB model.9 It specifies that HIV-related health behaviors depend on the degree to
which individuals have information about their condition and its treatment and the
behavioral skills needed to perform related behaviors (eg, remembering to take
medications). These elements are thought to contribute to individuals’ motivation to take
their medications. Since information and content about behavioral skills can readily be
provided in an electronic format, the IMB model is a useful framework to organize content
provided by an electronic intervention. While detailed interventions focused on changing
patients’ beliefs, attitudes, and skills are likely to still be needed in order for them to achieve
optimal levels of adherence, basic information leading to changes in adherence behaviors
can be provided and reinforced in an automated intervention. The purpose of this study was
thus to evaluate the extent to which an electronic intervention targeting health literacy and
organized by the elements of the IMB model could improve patients’ health literacy and
medication adherence.
Method
Overview
The strategy followed in this study included the following steps: (1) initial development of
intervention content and conversion into an electronic format, (2) preliminary testing of the
intervention’s content, usability, and acceptability to likely users, and (3) assessing the effect
of the intervention on participants’ information, motivation, and behavioral skills as well as
their medication adherence.
Initial development
Content for the intervention was initially developed through a survey of existing patient
education materials with review by a multidisciplinary team that included representatives
from medicine, nursing, psychology, pharmacy, and social work. The content was organized
into sections that focused on basic HIV-related information (viral life cycle and mechanism
of action of medications), factors and possible barriers related to motivation (misconceptions
about medications and strategies for coping with stigma, depression, and substance abuse),
and behavioral skills (strategies to remember to take medications). The content was
presented in an interactive and tailored format, with automated responses using the
participant’s name. After presentation of specific information elements, participants were
asked to respond to multiple choice questions about the information presented. If they
responded correctly, the intervention moved on to the next element; if not, the material was
presented again.
Content targeting barriers to adherence included material on coping and obtaining help with
depression and substance abuse and counteracting common misconceptions about
medications such as the desirability of avoiding medications after drinking alcoholic
beverages.20 Content intended to assist participants in developing behavioral skills included
the presentation of several strategies for sustained medication adherence such as the use of
reminders, scheduling medications together with other daily activities such as meals, and
enlisting social support. Given the increasing evidence for the importance of health
numeracy in general and the authors’ own research on the importance of numeracy for
adherence,21 some content specifically focused on translating numeric concepts into easily
understood formats. Specific content was translated into a multimedia format supported by
pictures, diagrams, and a brief animation of the viral life cycle.
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The intervention was created using a widely available software program, Adobe®
Captivate® (Version 4, Adobe Corporation, San Jose, CA). This software provides designers
the ability to create a multimedia program with graphic and video elements that can be
output in a format (Flash® Player; Adobe) that plays on most computers. The program
allows the designer to include multiple choice questions that enhance participant learning,
and the program can branch to different content based on participant responses. It was thus
possible to assess participant learning in an ongoing fashion and provide review of the
content for participants who did not demonstrate mastery. The approximately 1-hour long
intervention was delivered on stock touch screen computers (HP® TouchSmart series;
Hewlett-Packard Company, Palo Alto, CA). All text was recorded and provided to
participants over built-in speakers from the computer. Development costs were kept to a
minimum by using low-cost or open-source media.
Usability and acceptability
The content and format of the intervention was initially assessed by observing an initial
group of five potential users of the intervention as they interacted with it and were asked to
“think out loud” as they did so. Following this observation, participants were debriefed
about the intervention content and its usability. After completing this process with five
participants, the content and navigation of the scheme of the intervention was revised and
tested with a second group of five potential users. Content changes over the course of pilot
testing included changes in emphasis on the use of religious services for mental health
services and a reduction in complexity of the explanations of medication effects. Navigation
element changes included the addition of a “back” button allowing the user to review
previous screens. Only minor revisions were required after the second group, and the study
proceeded.
Assessment of intervention effects
The intervention was administered using stock touch screen computers (HP TouchSmart
300; Hewlett-Packard) with a 20-inch (diagonal) screen that required minimal computer
skills to use – participants could respond to assessment questions simply by touching the
correct answer on the computer screen.
Participants—Participants were recruited from the local practices of physicians treating
persons with HIV infection and through participants’ referral of other persons treated for
HIV infection in Broward County, FL, including the city of Fort Lauderdale. The county is
primarily urban and suburban. The county has a total population of 1,780,000 which is 67%
white and 27% black, and 12% of its residents have incomes that are within the United
States government’s definition of poverty.22 More than 16,000 persons in the area are living
with HIV/acquired immunodeficiency syndrome, of whom 71% are men and 29% women,
and 50% are black and 34% white.23
Measures—Because a number of studies have shown that cognitive abilities including
health literacy are important predictors of medication adherence,24–26 participants’ cognitive
status was assessed with a battery of measures. The measures that comprise the assessment
battery for this study were selected to assess health literacy using the full-length version of
the Test of Functional Health Literacy in Adults (TOFHLA).27 TOFHLA is a measure of a
person’s ability to understand written passages of health care-related text (reading subscale)
and to understand and apply quantitative data information related to medication taking,
laboratory values, and health finance (numeracy subscale). The battery also included a
measure of executive function using the Trail Making Test, Parts A and B.28 This measure
requires the person assessed to rapidly draw a line with a pencil between numbers (Trails A)
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and alternative numbers and letters (Trails B). While Trails A is often interpreted as a
measure of psychomotor speed, Trails B requires attention, memory, and mental switching.
Memory was assessed with the immediate and delayed recall trials of the Logical Memory
subtest of the Wechsler Memory Scale – Fourth Edition.29 This measure requires
participants to attend to and remember the elements of two brief stories. Participants are
asked to remember the elements immediately after hearing the stories in the immediate
recall trial and after 20 minutes in the delayed recall trial. Scores for this measure are
normalized on a large national sample and have a mean value of ten and a standard deviation
of three.
The LifeWindows IMB scale, a self-report measure of participants’ understanding of the
elements of the IMB model, was included in order to assess the intervention’s effects on the
elements of the model.30 It yields a subscale score for each of the elements of the IMB
model. The Adult Acquired Immunodeficiency Syndrome Clinical Trials Group baseline
adherence questionnaire was included during the first study visit.31 All rating scale measures
were administered via audio computer-assisted self-interview using the Questionnaire
Development System (QDS™, QDS Version 2.6; Nova Research Company, Bethesda, MD).
Medication adherence—Participants’ medication adherence was assessed using the
Medication Event Monitoring System (MEMS™; Aardex Group Ltd, Sion, Switzerland).
MEMS includes a device that electronically records each time a target medication’s pill
bottle is opened, serving as a measure of how the participant took his or her medication. The
information is read into a computer and a program provides a measure of the extent to which
the participant took his or her medication each day during the period observed. In this study,
the MEMS index calculated by the number of correct doses taken during each 24-hour
period was used as the index of adherence. This strategy takes into account the importance
of the correct timing of doses for viral suppression.32,33
These included an assessment of health literacy using the full-length version of TOFHLA,27
executive function using the Trails A and Trails B,28 and memory using the immediate and
delayed recall trials of the Logical Memory subtest of the Wechsler Memory Scale – Fourth
Edition.29 A subset of these measures was used in the statistical analyses reported here.
Procedure
Evaluation of the intervention’s effects was completed over three visits at 1-month intervals.
At the first visit, participants completed initial assessments that included the cognitive
battery and were instructed in how to use the MEMS pill bottles. Participants were seen on a
second occasion 1 month later when their baseline adherence was recorded and they
completed the electronic intervention. Participants were then seen on a third occasion during
which their post-intervention medication adherence was recorded.
Data analyses
All data were collected by the senior author or his research assistant and analyzed by the
senior author. The effectiveness of the intervention was evaluated in a pre–post design using
repeated measures analysis of covariance (ANCOVA) models. Models corrected for
participants’ demographic characteristics (age, gender, race, and education), cognitive
abilities (memory, executive function, and health literacy), and treatment variables (years of
treatment and number of HIV medications). Changes in adherence were evaluated over two
data points (for the months immediately before and after the participant completed the
intervention). A substantial number of participants had high levels of adherence at baseline
as measured by MEMS (greater than 90%), suggesting that analyses might be complicated
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by the presence of ceiling effects in adherence since participants who already had high
levels of adherence could not increase their level of adherence very much in response to the
intervention. Change in adherence was therefore explored for subgroups of participants with
lower levels of adherence (less than 95%, less than 90%, less than 85%, and less than 80%).
Model-corrected predicted levels of adherence before and after the intervention were
calculated for each subgroup to assess their degree of response to the intervention.
Changes in participants’ self-reported information, motivation, and behavioral skills were
assessed in repeated measures ANCOVA models for each subscale of the LifeWindows
questionnaire. The impact of changes in information, motivation, and behavioral skills on
participants’ medication adherence was assessed in a regression model that corrected for
demographic variables, baseline levels of health literacy and general cognitive ability, and
memory.
The study was completed under a protocol approved by the Nova Southeastern University
Institutional Review Board (Fort Lauderdale, FL). Written informed consent was obtained
from all participants prior to their entry into the study.
Results
Data collection and study visits began in May 2010 and continued until December 2011.
There were 124 participants enrolled in the study who completed the first visit. Of these, 120
returned for the second visit during which they completed the intervention. Reasons for the
four participants not returning for the second visit were: withdrawing consent due to illness
and the time demands of the study (one participant), loss to follow-up in spite of multiple
attempts to contact (one), and incarceration (two). Complete data for statistical analysis were
available for 109 participants. Missing data resulted from some participants’ difficulty in
completing some measures (eg, not responding to an item) and to the loss of two participants
between the intervention study visit and follow-up. One person moved from the area, and
another was incarcerated.
Descriptive statistics for the sample of participants who completed the intervention are
presented in Table 1 (risk factors for infection [Table 1A] and education [Table 1B]), Table
2 (continuous variables describing participants), and Table 3 (continuous variables for
measures used in the study). Participants reported a wide range of educational backgrounds
and included both heterosexual and homosexual sex as risk factors for infection as well as
substance use and transfusions. They also had a wide range of experiences with treatment,
ranging from a few months to several years, and a range of regimen complexities.
Medications monitored in evaluation of each participant’s level of adherence (chosen
according to most frequent dosing or highest likelihood of side effects) were protease
inhibitors (62 participants; 52%) combination medications (34 participants; 28%), integrase
inhibitor (13 participants; 11%), non-nucleoside reverse transcriptase inhibitor (eight
participants; 7%), and nucleoside reverse transcriptase inhibitor (three participants; 3%).
Women and blacks reported lower levels of educational attainment, although only the
relation of women to lower levels of education approached conventional levels of statistical
significance. White men were more likely to report having sex with another man as a risk
factor, while blacks in the sample reported lower levels of educational attainment.
Participants’ levels of health literacy can be interpreted according to cutoff values provided
for the TOFHLA by its authors,27 with a total score less than 59 representing “inadequate”
health literacy, scores in the range from 60–74 “marginal,” and greater than 75 “adequate”
health literacy. In this sample, six participants had inadequate, ten marginal, and 108 had
adequate levels of health literacy. It can be seen that the average score on the measure was
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in the adequate range, although the range of scores shows that a wide range of health literacy
was present in the sample. A histogram of participants’ baseline levels of adherence is
presented in Figure 1.
Results of the repeated measures ANCOVA model for participants with less than 95%
baseline adherence are summarized in Table 4. This analysis showed a significant effect for
time before and after the intervention, although the change in adherence for this group was
small (2.3%; Figure 2). The same model was evaluated for subgroups of participants based
on progressively lower levels of baseline adherence cutoffs (less than 90% to less than 70%
at 5% intervals). Table 4 also presents a significant effect of time by TOFHLA numeracy.
Evaluation of the direction of the relationship through graphing (not presented) showed that
participants with lower levels of numeracy showed greater increases in adherence after
completing the intervention than did those with higher levels.
Results for the effect of time only for each subgroup are reported in Table 5. As the sample
size with which each model was calculated became progressively smaller and thus had
limited power to detect a statistically significant effect, the effect size for each model was
also calculated and is reported. Analyses of pre–post differences for the entire group did not
result in a statistically significant effect for time and showed a small effect size. For
subgroups with lower levels of baseline adherence, however, the intervention was associated
with increasingly larger changes in adherence. Effect size, however, was largest for the
group with baseline adherence less than 85% (mean baseline adherence of 58%; effect size
of 0.17, ie, a large effect size).34 Effect size depends not only on the magnitude of change
observed but also the subsample’s underlying variability; it is possible that the intervention
was differentially effective for some participants in these groups. The relation of baseline
adherence to change in adherence and to effect size of the intervention is illustrated in
Figures 2 and 3, respectively.
Repeated measures ANCOVA models for change over time in information, motivation, and
behavioral skills (LifeWindows questionnaire subscales30) showed that participants’ report
of their knowledge and behavioral skills increased significantly over the course of the study
(effect of time for information F [2, 96] = 4.25, P = 0.02 and effect of time for behavioral
skills F [2, 96] = 4.17; P = 0.02). The effect of time for motivation was not significant
(effect of time F [2, 96] = 0.67; P = 0.51). Regression models evaluating the impact of
changes in information, motivation, and behavioral skills on participants’ medication
adherence showed that change in information over the course of the study was a significant
predictor of medication adherence at the final study visit (χ2 = 7.35; degrees of freedom = 1;
P = 0.001). Models evaluating the impact of change in motivation and behavioral skills
showed that they were not significant predictors of adherence (P > 0.10).
Discussion
The purpose of these analyses was to evaluate the relation of baseline levels of medication
adherence on participants’ response to an electronically delivered intervention that targeted
patients’ health literacy as a way of improving their medication adherence. Results suggest
that there is a relationship between baseline adherence and response to the intervention, with
those with lower baseline levels of adherence showing the largest changes after the
intervention. Observed effect sizes for the intervention mirrored in part these findings, with
the intervention resulting in large effect sizes for those with lower levels of adherence up to
58%, but then showed decreasing effect sizes.34 The smaller change observed in participants
with higher levels of adherence can be attributed to a ceiling effect, since participants with
high levels of adherence at baseline could not increase their adherence by a large amount.
Participants with 95% baseline adherence, for example, could only increase their adherence
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by a maximum of 5%, while those with levels of adherence less than 70% could increase
their adherence by substantially greater amounts. The finding of decreased effect sizes for
those with the lowest levels of adherence may be related to increased variability in the
subsamples as effect size depends not only on change but also on underlying variability.
There may be many reasons for persons to have low levels of adherence, such as lack of
financial resources, that could not be addressed by the computer intervention. Finally, in
other analyses it was shown that participants’ self-report of HIV-related knowledge and
behavioral skills increased over the course of the study, and their change in information
predicted their post-intervention medication adherence.
Several of the models presented in Table 5 did not result in a statistically significant change
in adherence over time. For analysis of the entire sample, this can be interpreted as the result
of including a number of persons with high levels of adherence. For analyses of subgroups
with lower levels of baseline adherence, the failure to find a statistically significant effect for
time may be the result of the reduced sample size associated with these analyses.
Limitations of this report include the post hoc nature of the analyses, the lack of a control
group for comparisons of the intervention’s effects, and the need to account for a large
number of cognitive covariates in analyses of treatment effects. Analyses of subgroups
selected after initial study design are associated with the risk of spurious findings of
statistical significance. In these analyses, resolving this problem was attempted by
examining the data for a pattern in findings across the subgroups. As illustrated in Figure 2,
a relationship between baseline adherence and change in adherence in response to the
intervention appears consistent across subgroups, even though tests of the effect are
statistically significant only for some subgroups.
Another limitation is the research design employed that did not include a control group. The
design of the study, intentionally created as an exploratory investigation of the intervention’s
potential effects, precluded the incorporation of a control group. Because of this design, the
possibility that the effects of the intervention observed in these analyses were simply the
result of participants’ inclusion in the study cannot be excluded. It is possible that simply
participating in the study resulted in increases in adherence, although it should be noted that
observed changes in adherence occurred between the participants’ entry into the study and
their exposure to the intervention. This issue was addressed in analyses that assessed
changes in participants’ information, motivation, and behavioral skills across the course of
the study and the relation of changes to participants’ ultimate medication adherence. These
results showed that participants’ information and behavioral skills increased significantly
over the course of the study, and that changes in information predicted their medication
adherence at the study’s conclusion. This suggests that participants’ response to the
intervention rather than the general effects of study participation was related to their
adherence. A more definitive evaluation of the effects of the study intervention depends on
further evaluation in more a rigorous study design.
ANCOVA models reported here include a substantial number of covariates. The inclusion of
covariates in ANCOVA models increases statistical power by allowing a more precise
determination of the intervention’s effects by accounting for external influences that might
affect participants’ responses. In the models reported here, the effects of standard
demographic variables shown in other studies to have an effect on adherence were taken into
account (gender, race, age, and education). In order to evaluate participants’ response to the
intervention, the effects of memory were also considered important. Finally, as the
intervention was targeted at improving participants’ health literacy, their baseline level of
health literacy was also taken into account in evaluating their response to the intervention. It
can be noted that in the model for participants with less than 95% adherence, an interaction
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between baseline health numeracy and change in adherence over time was observed (Table
4). Examination of the interaction showed that participants with lower baseline scores on
numeracy showed greater changes in adherence from first to second assessments of their
adherence. A particular focus of the intervention development was an attempt to
communicate numeric data to participants in ways that could be easily understood. This was
done by presenting numeric data on the meaning of 95% adherence in a graphic format (a
calendar) that illustrated precisely how many doses a month the patient could miss and still
have 95% adherence. Several participants commented during the study that this was helpful
to them. The finding of the interaction suggests that the effort to communicate the precise
meaning of high levels of adherence in clear behavioral terms may have been helpful.
Other studies of electronic interventions have shown that they can have positive impact on
patients’ health. A study that evaluated the efficacy of computer cognitive behavioral
therapy for depression showed that it was effective.35 A computer-based application that
focused on smoking cessation in primary care patients was also effective.36 Other electronic
interventions, including those delivered by telephone or text messaging, have been effective
in improving medication adherence.37
Conclusion
Results of this study thus show that an electronically delivered intervention designed to
improve patients’ health literacy may have an effect on participants’ medication adherence.
Analyses of subgroups across baseline levels of adherence further suggest that participants
with lower levels of adherence may show a larger response to the intervention. Electronic
interventions for adherence may be a useful strategy to provide an adherence intervention.
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Figure 1.
Histogram of participants’ baseline adherence.
Ownby et al. Page 12
Neurobehav HIV Med. Author manuscript; available in PMC 2013 January 03.
$watermark-text
$watermark-text
$watermark-text
Figure 2.
Change in adherence as a function of baseline adherence.
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Figure 3.
Intervention size as a function of baseline adherence.
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Table 1
A Description of sample for categorical variables: self-report of how infection occurred
How participant became
infected (self-report)
Men
n = 88
Women
n = 36
Blacks
n = 78
Whites
n = 45
Sex with man 47 (53%) 29 (81%) 38 (49%) 38 (84%)
Sex with woman 37 (42%) 6 (17%)‡ 37 (47%) 6 (13%)
Shared needles 16 (18%) 4 (11%) 10 (13%) 10 (22%)
Transfusion 9 (10%) 6 (17%) 12 (15%) 3 (7%)
Other 9 (10%) 2 (6%) 7 (9%) 4 (9%)
Don’t know 21 (24%) 11 (31%) 29 (37%) 3 (7%)
Totals† 139 58 133 64
B Description of sample for categorical variables: education
Education Men Women† Blacks Whites‡
11th grade or less 29 (33%) 17 (47%) 42 (54%) 4 (9%)
High school or GED 30 (34%) 15 (42%) 24 (31%) 21 (47%)
2-year college/AA/technical college 17 (19%) 1 (3%) 7 (9%) 11 (24%)
College graduate 9 (10%) 2 (6%) 3 (4%) 8 (18%)
Master degree or greater 2 (2%) 0 (0%) 1 (1%) 1 (2%)
Notes:
†
Exceed sample size due to several participants indicating multiple risk factors;
‡
of the women reporting sex with another woman as a risk factor, only one did not report another risk factor, such as sex with a man or sharing
needles.
Notes:
†
Test of the association of gender and educational status: χ2 = 8.12 (degrees of freedom = 4), P = 0.09;
‡
test of the association of race and educational status: χ2 = 28.31 (degrees of freedom = 4), P < 0.001.
Abbreviations: AA, Associate in Arts; GED, General Educational Development.
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